Okuno, S., Bailey, H., Mahoney, M. R., Adkins, D., Maples, W., Fitch, T., . . . Sarkaria, J. N. (2011). A Phase 2 Study of Temsirolimus (CCI-779) in Patients With Soft Tissue Sarcomas: A Study of the Mayo Phase 2 Consortium (P2C).

Okuno, Scott, Howard Bailey, Michelle R. Mahoney, Douglas Adkins, William Maples, Tom Fitch, David Ettinger, Charles Erlichman, and Jann N. Sarkaria. A Phase 2 Study of Temsirolimus (CCI-779) in Patients With Soft Tissue Sarcomas: A Study of the Mayo Phase 2 Consortium (P2C). 2011.

Okuno, Scott, et al. A Phase 2 Study of Temsirolimus (CCI-779) in Patients With Soft Tissue Sarcomas: A Study of the Mayo Phase 2 Consortium (P2C). 2011.